Loading...
West Pharmaceutical Services, Inc.
WST•NYSE
Healthcare
Medical - Instruments & Supplies
$263.51
$-15.59(-5.59%)
West Pharmaceutical Services, Inc. (WST) Financial Performance & Income Statement Overview
Review West Pharmaceutical Services, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-1.92%
↓ 1.92%
Operating Income Growth
-15.70%
↓ 15.70%
Net Income Growth
-16.97%
↓ 16.97%
Operating Cash Flow Growth
-15.85%
↓ 15.85%
Operating Margin
19.65%
↑ 19.65%
Gross Margin
35.27%
↑ 35.27%
Net Profit Margin
16.48%
↑ 16.48%
ROE
24.03%
↑ 24.03%
ROIC
64.01%
↑ 64.01%
West Pharmaceutical Services, Inc. (WST) Income Statement & Financial Overview
Review West Pharmaceutical Services, Inc.'s (WST) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $698.00M | $748.80M | $746.90M | $702.00M |
| Cost of Revenue | $466.10M | $475.20M | $482.20M | $470.70M |
| Gross Profit | $231.90M | $273.60M | $264.70M | $231.30M |
| Gross Profit Ratio | $0.33 | $0.37 | $0.35 | $0.33 |
| R&D Expenses | $16.30M | $18.50M | $15.50M | $17.50M |
| SG&A Expenses | $88.00M | $85.30M | $83.50M | $83.00M |
| Operating Expenses | $124.90M | $114.00M | $99.00M | $100.50M |
| Total Costs & Expenses | $570.40M | $589.20M | $581.20M | $571.20M |
| Interest Income | $4.10M | $4.80M | $4.60M | $4.00M |
| Interest Expense | $400000.00 | -$800000.00 | $700000.00 | $1.50M |
| Depreciation & Amortization | $40.00M | $40.70M | $40.20M | $38.90M |
| EBITDA | $150.90M | $204.80M | $205.40M | $168.40M |
| EBITDA Ratio | $0.22 | $0.27 | $0.28 | $0.24 |
| Operating Income | $107.00M | $159.60M | $161.30M | $130.80M |
| Operating Income Ratio | $0.15 | $0.21 | $0.22 | $0.19 |
| Other Income/Expenses (Net) | $3.50M | $5.30M | $3.20M | $7.00M |
| Income Before Tax | $110.50M | $164.90M | $164.50M | $128.70M |
| Income Before Tax Ratio | $0.16 | $0.22 | $0.22 | $0.18 |
| Income Tax Expense | $24.10M | $36.80M | $32.40M | $21.90M |
| Net Income | $89.80M | $130.10M | $136.00M | $111.30M |
| Net Income Ratio | $0.13 | $0.17 | $0.18 | $0.16 |
| EPS | $1.24 | $1.78 | $1.87 | $1.52 |
| Diluted EPS | $1.23 | $1.77 | $1.85 | $1.51 |
| Weighted Avg Shares Outstanding | $72.50M | $73.00M | $72.80M | $73.00M |
| Weighted Avg Shares Outstanding (Diluted) | $73.00M | $73.70M | $73.40M | $73.70M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan